BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

103 related articles for article (PubMed ID: 1334041)

  • 1. Internalization of monoclonal antibodies selected for immunotoxin activity against small-cell lung cancer.
    Weltman JK; Melucci CL; Chen J; Davidson AE
    Hybridoma; 1992 Oct; 11(5):547-59. PubMed ID: 1334041
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Rapid screening with indirect immunotoxin for monoclonal antibodies against human small cell lung cancer.
    Weltman JK; Pedroso P; Johnson SA; Davignon D; Fast LD; Leone LA
    Cancer Res; 1987 Nov; 47(21):5552-6. PubMed ID: 2822229
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Immunotoxin therapy of small-cell lung cancer: a phase I study of N901-blocked ricin.
    Lynch TJ; Lambert JM; Coral F; Shefner J; Wen P; Blattler WA; Collinson AR; Ariniello PD; Braman G; Cook S; Esseltine D; Elias A; Skarin A; Ritz J
    J Clin Oncol; 1997 Feb; 15(2):723-34. PubMed ID: 9053498
    [TBL] [Abstract][Full Text] [Related]  

  • 4. A new small cell lung cancer (SCLC)-specific marker discovered through antigenic subtraction of neuroblastoma cells.
    Krueger P; Nitz C; Foster R; MacDonald C; Gelber O; Lalehzadeh G; Goodson R; Winter J; Gelber C
    Cancer Immunol Immunother; 2003 Jun; 52(6):367-77. PubMed ID: 12669243
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Anti-tumor activity of a blocked ricin immunotoxin with specificity against the cluster-5A antigen associated with human small-cell lung cancer.
    Zangemeister-Wittke U; Collinson AR; Fisch I; Jones RM; Waibel R; Lehman HP; Stahel RA
    Int J Cancer; 1993 Jul; 54(6):1028-35. PubMed ID: 8392978
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Markedly different antibody responses to immunized small cell and non-small cell lung cancer cells.
    Doyle LA; Cuttitta F; Mulshine JL; Bunn PA; Minna JD
    Cancer Res; 1987 Oct; 47(19):5009-13. PubMed ID: 3040237
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Cytotoxic activity of ricin A chain immunotoxins recognising cluster 1, w4 and 5A antigens associated with human small cell lung cancer.
    Wawrzynczak EJ; Derbyshire EJ; Henry RV; Parnell GD; Smith A; Waibel R; Stahel RA
    Br J Cancer Suppl; 1991 Jun; 14():71-3. PubMed ID: 1645577
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Elimination of neuroblastoma and small-cell lung cancer cells with an anti-neural cell adhesion molecule immunotoxin.
    Roy DC; Ouellet S; Le Houillier C; Ariniello PD; Perreault C; Lambert JM
    J Natl Cancer Inst; 1996 Aug; 88(16):1136-45. PubMed ID: 8757193
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Antibody internalization after cell surface antigen binding is critical for immunotoxin development.
    Kuo SR; Alfano RW; Frankel AE; Liu JS
    Bioconjug Chem; 2009 Oct; 20(10):1975-82. PubMed ID: 19785403
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Characterization of two human small cell lung carcinoma-reactive monoclonal antibodies generated by a novel immunization approach.
    Tong AW; Lee J; Stone MJ
    Cancer Res; 1984 Nov; 44(11):4987-92. PubMed ID: 6207911
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Potent cytotoxic action of the immunotoxin SWA11-ricin A chain against human small cell lung cancer cell lines.
    Derbyshire EJ; Henry RV; Stahel RA; Wawrzynczak EJ
    Br J Cancer; 1992 Sep; 66(3):444-51. PubMed ID: 1325825
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Intratumoral anti-HuD immunotoxin therapy for small cell lung cancer and neuroblastoma.
    Ehrlich D; Wang B; Lu W; Dowling P; Yuan R
    J Hematol Oncol; 2014 Dec; 7():91. PubMed ID: 25523825
    [TBL] [Abstract][Full Text] [Related]  

  • 13. [Monoclonal antibodies in the diagnosis and therapy of lung cancer].
    Campobasso N; Dammacco F
    Recenti Prog Med; 1991 Dec; 82(12):642-51. PubMed ID: 1667710
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Discrimination of human small cell and non-small cell lung tumors by a panel of monoclonal antibodies.
    Tong AW; Lee JC; Stone MJ
    J Natl Cancer Inst; 1986 Nov; 77(5):1023-33. PubMed ID: 3022055
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Immunotoxin therapy of small-cell lung cancer. N901-blocked ricin for relapsed small-cell lung cancer.
    Lynch TJ
    Chest; 1993 Apr; 103(4 Suppl):436S-439S. PubMed ID: 8384975
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Monoclonal antibody SEN7 recognizes a new epitope on the neural cell adhesion molecule present on small cell lung cancer but not on lymphocytes.
    Waibel R; Mannhart M; O'Hara CJ; Brocklehurst C; Zangemeister-Wittke U; Schenker T; Lehmann HP; Weber E; Stahel RA
    Cancer Res; 1993 Jun; 53(12):2840-5. PubMed ID: 7684948
    [TBL] [Abstract][Full Text] [Related]  

  • 17. [Monoclonal antibodies to human small-cell lung cancer].
    Goncharskaia MA; Rutkevich IM; Tonevitskiĭ AG; Orel NF; Vasil'ev AV; Perevodchikova NI; Mechetner EB
    Biull Eksp Biol Med; 1991 Sep; 112(9):282-5. PubMed ID: 1660741
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Monoclonal antibodies recognising the cluster 2 antigen associated with human small cell lung cancer mediate the toxic effects of ricin A chain in an indirect assay of immunotoxin cytotoxicity.
    Derbyshire EJ; Wawrzynczak EJ
    Br J Cancer Suppl; 1991 Jun; 14():74-7. PubMed ID: 1645578
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Refinement of an indirect immunotoxin assay of monoclonal antibodies recognising the human small cell lung cancer cluster 2 antigen.
    Derbyshire EJ; de Leij L; Wawrzynczak EJ
    Br J Cancer; 1993 Jun; 67(6):1242-7. PubMed ID: 8390281
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Specific cell targeting for delivery of toxins into small-cell lung cancer using a streptavidin fusion protein complex.
    Yu A; Choi J; Ohno K; Levin B; Rom WN; Meruelo D
    DNA Cell Biol; 2000 Jul; 19(7):383-8. PubMed ID: 10945228
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.